INFORMATION FOR
News
With the permission of Yale School of Medicine, the Department of Internal Medicine’s leadership recommended that the voting privileges of professors in the academic clinician track be expanded to include all faculty appointments and promotions during the A&P process. The senior and tenured faculty has officially voted to approve this change as a new departmental policy.
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.
As a part of our “Meet Yale Internal Medicine” series, today’s feature is on Stephanie Thorn, MSc, PhD, assistant professor (cardiology) and the associate director of the Yale Translational Imaging Center (Y-TRIC)
The quest for personalized medicine, a medical approach in which practitioners use a patient’s unique genetic profile to tailor individual treatment, has emerged as an important goal in the health care sector. But a new Yale-led study shows that the mathematical models currently available to predict treatments have limited effectiveness.
Attila Feher, MD, PhD, has been named as Ones to Watch in 2023 by the Society of Nuclear Medicine and Molecular Imaging.
Three scholars join the Cardiology Fellowship Educational Team.
Dr. Robert W. Elder to provide leadership to Connecticut Board of Directors of the American Heart Association (AHA).
The Yale Cooperative Center of Excellence in Hematology (YCCEH) has appointed John Hwa MD, PhD, as the joint director.
The Innovative Project Award will support high-potential research that could lead to critical discoveries for people with sarcoidosis
The Blavatnik Fund for Innovation at Yale provides a real-world setting for faculty to develop biomedical research.
Carlos Mena-Hurtado, MD, specializes in the management of vascular disease and the advancement of cardiovascular health.
Carlos Mena-Hurtado, MD, has been appointed to serve on the American Heart Association (AHA) Council on Peripheral Vascular Disease (PVD) as a member at large of the PVD Leadership Committee and a member PVD Nominating Committee.
Attila Feher, MD, PhD, has been selected for the American Society of Nuclear Cardiology (ASNC) Leadership Development Program.
Connecticut Magazine's 2023 ‘Top Doctors’ list includes 16 faculty in the Section of Cardiovascular Medicine.
Distress is associated with an increased risk of mortality and major amputation after peripheral vascular intervention (PVI).
Samit Shah, MD, PhD, was appointed to serve on the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Oversight Committee.
Carlos Mena-Hurtado, MD, was appointed to serve on the Society for Vascular Surgery Patient Safety Organization (SVS PSO) Governing Council.
The ABMR Early-Stage Investigator Award supports rising leaders in behavioral medicine research.
Harlan Krumholz, MD, discusses his new framework for improving hypertension outcomes.
Yale provides cardiovascular risk assessment and treatment for patients with autoimmune diseases, including rheumatoid arthritis, systemic lupus, scleroderma, psoriatic arthritis, and vasculitis.